Latest News about OCUL
Recent news which mentions OCUL
Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session
November 08, 2022
From Benzinga
From Benzinga
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
October 05, 2022
From InvestorPlace
From Benzinga
From Benzinga
Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session
September 30, 2022
From Benzinga
Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday
September 30, 2022
From Benzinga
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
September 28, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 27, 2022
From Benzinga
Avidity Biosciences, Kronos Worldwide And Some Other Big Stocks Moving Lower On Tuesday
September 27, 2022
From Benzinga
Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session
September 27, 2022
From Benzinga
Ocular Therapeutix's Wet AMD Candidate Shows Sustained, Comparable Clinical Activity Vs. Eylea
September 27, 2022
From Benzinga
Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket
September 22, 2022
From Benzinga
Earnings Scheduled For August 8, 2022
August 08, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
May 27, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
May 26, 2022
From Benzinga
Earnings Scheduled For May 9, 2022
May 09, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
April 21, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
April 20, 2022
From Benzinga
The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
April 17, 2022
From Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
February 18, 2022
From Benzinga
Ocular Therapeutix's Dexamethasone Ophthalmic Insert Meets Primary Goal In Dry Eye Disease Trial
December 06, 2021
Tickers
OCUL
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.